GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

Sanofi is conducting the two-part multicenter, randomized, open-label, controlled, parallel-group study (NCT04643002) to evaluate the safety, efficacy, pharmacokinetics and biomarker data of ...

A photography exhibition of secondary breast cancer patients is aiming to raise awareness of the signs of metastasis. Photographer Abigail Fahey, from Worthing in West Sussex, has captured images ...

2024). Currently, advanced secondary cancers are typically only detected after multiple metastases have already occurred. The challenges associated with detecting dormant cancer cells or small ...

Receiving radiation therapy for breast cancers harboring TP53 germline variants may cause secondary cancers, but risk estimates are unconfirmed. Patients with breast cancer who carry TP53 germline ...

But neighbourhood secondary schools, some of which are quite young, are getting in on the act too and are finding new ways to build and expand these volunteer networks with the hope that it will ...

Other innovative medicines like Nexviazyme, Rezurock, and Sarclisa continue to perform ... based on alpha-emitting isotopes for rare cancers. We will keep you updated as we continue to access ...